Exane Derivatives’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | $1.23K | Sell |
151
-2,076
| -93% | -$16.9K | ﹤0.01% | 485 |
|
2022
Q1 | $27.1K | Sell |
2,227
-1,533
| -41% | -$18.6K | 0.01% | 633 |
|
2021
Q4 | $128K | Buy |
3,760
+277
| +8% | +$9.45K | 0.03% | 410 |
|
2021
Q3 | $168K | Sell |
3,483
-576
| -14% | -$27.8K | 0.04% | 419 |
|
2021
Q2 | $183K | Sell |
4,059
-1,321
| -25% | -$59.7K | 0.04% | 422 |
|
2021
Q1 | $259K | Sell |
5,380
-2,273
| -30% | -$110K | 0.07% | 247 |
|
2020
Q4 | $412K | Buy |
+7,653
| New | +$412K | 0.12% | 190 |
|